Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans

被引:98
作者
Mondon, P
Petter, R
Amalfitano, G
Luzzati, R
Concia, E
Polacheck, I
Kwon-Chung, KJ
机构
[1] NIAID, Clin Invest Lab, MMS, NIH, Bethesda, MD 20892 USA
[2] Univ Hosp Verona, Verona, Italy
[3] Hadassah Med Ctr, IL-91120 Jerusalem, Israel
关键词
D O I
10.1128/AAC.43.8.1856
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cryptococcus neoformans isolates that exhibited unusual patterns of resistance to fluconazole and voriconazole were isolated from seven isolates from two different geographical regions: one isolate from an Israeli non-AIDS patient and six serial isolates fi om an Italian AIDS patient who had suffered six recurrent episodes of cryptococcal meningitis. Each isolate produced cultures with heterogeneous compositions in which most of the cells were susceptible, but cells highly resistant to fluconazole (MICs, greater than or equal to 64 mu g/ml) were recovered at a variable frequency (7 x 10(-3) to 4.6 x 10(-2)), Evidence showed that this type of resistance is innate and is unrelated to drug exposure since the Israeli patient had never been treated with azoles or any other antimycotic agents. Analysis of clonal subpopulations of these two strains showed that they exhibited heterogeneous patterns of resistance. The number of subpopulations which grew on fluconazole or voriconazole agar declined progressively with increasing azole concentration without a sharp cutoff point, For the Italian serial isolates, the number of clonal populations resistant to fluconazole (64 mu g/ml) and voriconazole (1 mu g/ml) increased steadily, yielding the highest number for the isolate from the last episode. Attempts to purify a sensitive subpopulation failed, but clones highly resistant to fluconazole (100 mu g/ml) and moderately resistant to voriconazole (1 mu g/ml) always produced a homogeneous population of resistant cells. Upon maintenance on drug-free medium, however, the majority of the homogeneously resistant cells of these subclones lost their resistance and returned to the stable initial heteroresistant phenotype. The pattern of heteroresistance was not affected by the pH or osmolarity of the medium but was influenced by temperature. The resistance appeared to be suppressed at 35 degrees C and was completely abolished at 40 degrees C. Although heterogeneity in azole resistance among subpopulations of single isolates has been reported for Candida species, the transient changes in expression of resistance under different growth conditions reported here have not been observed in fungal pathogens.
引用
收藏
页码:1856 / 1861
页数:6
相关论文
共 34 条
[11]   SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS - A MICRODILUTION TECHNIQUE [J].
GHANNOUM, MA ;
IBRAHIM, AS ;
FU, Y ;
SHAFIQ, MC ;
EDWARDS, JE ;
CRIDDLE, RS .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2881-2886
[12]   EXPRESSION OF METHICILLIN RESISTANCE IN HETEROGENEOUS STRAINS OF STAPHYLOCOCCUS-AUREUS [J].
HARTMAN, BJ ;
TOMASZ, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (01) :85-92
[13]   Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans [J].
Kirkpatrick, WR ;
McAtee, RK ;
Revankar, SG ;
Fothergill, AW ;
McCarthy, DI ;
Rinaldi, MG ;
Patterson, TF .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (05) :1330-1332
[14]  
Kwon-Chwag KJ, 1992, MED MYCOL, P397
[15]   CLONING AND CHARACTERIZATION OF A GENE AFFECTING THE METHICILLIN RESISTANCE LEVEL AND THE AUTOLYSIS RATE IN STAPHYLOCOCCUS-AUREUS [J].
MAKI, H ;
YAMAGUCHI, T ;
MURAKAMI, K .
JOURNAL OF BACTERIOLOGY, 1994, 176 (16) :4993-5000
[16]   Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus [J].
Maki, H ;
Murakami, K .
JOURNAL OF BACTERIOLOGY, 1997, 179 (22) :6944-6948
[17]   Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR [J].
Marr, KA ;
Lyons, CN ;
Rustad, T ;
Bowden, RA ;
White, TC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2584-2589
[18]  
MATTHEWS PR, 1984, FEMS MICROBIOL LETT, V22, P161
[19]  
Nguyen MH, 1998, ANTIMICROB AGENTS CH, V42, P471
[20]  
ORNIWASSERLAUF R, 1998, 38 INT C ANT AG CHEM, P458